BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15968400)

  • 1. The role of CD40 in CD40L- and antibody-mediated platelet activation.
    Langer F; Ingersoll SB; Amirkhosravi A; Meyer T; Siddiqui FA; Ahmad S; Walker JM; Amaya M; Desai H; Francis JL
    Thromb Haemost; 2005 Jun; 93(6):1137-46. PubMed ID: 15968400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice.
    Robles-Carrillo L; Meyer T; Hatfield M; Desai H; Dávila M; Langer F; Amaya M; Garber E; Francis JL; Hsu YM; Amirkhosravi A
    J Immunol; 2010 Aug; 185(3):1577-83. PubMed ID: 20585032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40-CD40L interactions in platelet activation.
    Davì G; Ferroni P
    Thromb Haemost; 2005 Jun; 93(6):1011-2. PubMed ID: 15968380
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet CD40L Modulates Thrombus Growth Via Phosphatidylinositol 3-Kinase β, and Not Via CD40 and IκB Kinase α.
    Kuijpers MJ; Mattheij NJ; Cipolla L; van Geffen JP; Lawrence T; Donners MM; Boon L; Lievens D; Torti M; Noels H; Gerdes N; Cosemans JM; Lutgens E; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1374-81. PubMed ID: 25908768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice.
    Willecke F; Tiwari S; Rupprecht B; Wolf D; Hergeth S; Hoppe N; Dufner B; Schulte L; Anto Michel N; Bukosza N; Marchini T; Jäckel M; Stachon P; Hilgendorf I; Zeschky K; Schleicher R; Langer HF; von Zur Muhlen C; Bode C; Peter K; Zirlik A
    Thromb Haemost; 2014 Aug; 112(2):379-89. PubMed ID: 24652469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
    Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
    Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.
    Inwald DP; McDowall A; Peters MJ; Callard RE; Klein NJ
    Circ Res; 2003 May; 92(9):1041-8. PubMed ID: 12676820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
    Varo N; Libby P; Nuzzo R; Italiano J; Doria A; Schönbeck U
    Diab Vasc Dis Res; 2005 May; 2(2):81-7. PubMed ID: 16308911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
    Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
    Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil CD40 enhances platelet-mediated inflammation.
    Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
    Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of soluble CD40 ligand bioactivity with anti-CD40 antibodies.
    Schwabe RF; Hess S; Johnson JP; Engelmann H
    Hybridoma; 1997 Jun; 16(3):217-26. PubMed ID: 9219031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases.
    Xie JH; Yamniuk AP; Borowski V; Kuhn R; Susulic V; Rex-Rabe S; Yang X; Zhou X; Zhang Y; Gillooly K; Brosius R; Ravishankar R; Waggie K; Mink K; Price L; Rehfuss R; Tamura J; An Y; Cheng L; Abramczyk B; Ignatovich O; Drew P; Grant S; Bryson JW; Suchard S; Salter-Cid L; Nadler S; Suri A
    J Immunol; 2014 May; 192(9):4083-92. PubMed ID: 24670803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
    Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric investigation of CD40-CD40 ligand system in preeclampsia and normal pregnancy.
    Lukanov TH; Bojinova SI; Popova VS; Emin AL; Veleva GL; Gecheva SP; Konova EI
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):306-12. PubMed ID: 19221099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.
    Harding SA; Sarma J; Josephs DH; Cruden NL; Din JN; Twomey PJ; Fox KA; Newby DE
    Circulation; 2004 Apr; 109(16):1926-9. PubMed ID: 15078798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.
    Martínez de Lizarrondo S; Roncal C; Calvayrac O; Rodríguez C; Varo N; Purroy A; Lorente L; Rodríguez JA; Doeuvre L; Hervás-Stubbs S; Angles-Cano E; Páramo JA; Martínez-González J; Orbe J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1477-87. PubMed ID: 22492089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L.
    Neubauer H; Petrak F; Zahn D; Pepinghege F; Hägele AK; Pirkl PA; Uhl I; Juckel G; Mügge A; Herpertz S
    J Psychiatr Res; 2013 Jul; 47(7):865-71. PubMed ID: 23583028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.
    Amirkhosravi A; Amaya M; Desai H; Francis JL
    Blood Coagul Fibrinolysis; 2002 Sep; 13(6):505-12. PubMed ID: 12192302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway.
    Yacoub D; Hachem A; Théorêt JF; Gillis MA; Mourad W; Merhi Y
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2424-33. PubMed ID: 21071692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.